Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Anti-Cancer Agents in Medicinal Chemistry|July 21, 2021
Structural Aspects of mTOR Inhibitors: Search for Potential CompoundsKamalpreet Kaur, Arjun Anant, Vivek AsatiAnti-Cancer Agents in Medicinal Chemistry|June 7, 2016
Mutant B-Raf Kinase Inhibitors as Anticancer AgentsVivek Asati, Sanjay K Bharti, Debarshi K MahapatraEuropean Journal of Medicinal Chemistry|May 26, 2015
Anti-cancer chalcones: Structural and molecular target perspectivesDebarshi Kar Mahapatra, Sanjay Kumar Bharti, Vivek AsatiEuropean Journal of Medicinal Chemistry|October 1, 2016
K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectivesVivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar BhartiEuropean Journal of Medicinal Chemistry|December 3, 2014
Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agentsVivek Asati, Debarshi Kar Mahapatra, Sanjay K BhartiExpert Opinion on Therapeutic Patents|April 30, 2019
An updated patent review of therapeutic applications of chalcone derivatives (2014-present)Debarshi Kar Mahapatra, Vivek Asati, Sanjay Kumar BhartiMolecular Diversity|May 3, 2026
Integrating AI into next-generation PROTAC Engineering: a comprehensive toolkit for rational PROTAC designPitam Ghosh, Ryena Dhir, Dinki Sharma, et al.European Journal of Medicinal Chemistry|April 8, 2019
PIM kinase inhibitors: Structural and pharmacological perspectivesVivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar BhartiCurrent Topics in Medicinal Chemistry|September 16, 2017
Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets PerspectivesDebarshi Kar Mahapatra, Sanjay Kumar Bharti, Vivek AsatiFuture Medicinal Chemistry|January 21, 2026
Emerging roles of PARP-1 driven dual inhibitors in cancer therapy: SAR-guided strategies and synthetic lethalityRyena Dhir, Pitam Ghosh, Dinki Sharma, et al.Pageof 7